News | October 30, 2013

Philips and Infraredx Sign Agreement for Resale of Infraredx’s TVC Imaging System

Infraredx’s TVC imaging system to be sold alongside Philips' Allura interventional X-ray systems

Infraredx, TVC Imaging System, imaging, cardiac imaging

October 30, 2013 — Philips Healthcare and Infraredx Inc. announced a non-exclusive resale agreement for Infraredx’s TVC intravascular imaging system. Under the terms of the agreement, Philips will sell Infraredx’s TVC imaging system alongside its Allura interventional X-ray systems in North America and Europe, expanding its interventional cardiology portfolio of advanced live image-guidance solutions, clinical informatics and interventional tools.

The TVC imaging system is a first-in-class intravascular imaging system that integrates near-infrared spectroscopy lipid core plaque (LCP) detection technology, and intravascular ultrasound (IVUS) imaging to visualize the presence of plaques, quantify the degree of vessel stenosis and identify plaques prone to rupturing and causing dangerous blockages.

“Our goal is to further improve existing image-guided interventions and therapies and to enable new ones,” said Ronald Tabaksblat, general manager, interventional X-ray at Philips Healthcare. “By teaming up with Infraredx to sell the TVC imaging system, our product portfolio will be enhanced with an innovative intravascular imaging technology that works seamlessly with our interventional X-ray systems for better-informed treatment decisions and real-time therapy monitoring.”

“We’re pleased to partner with Philips, the leader in interventional X-ray systems, to expand access to our innovative TVC imaging system among Philips’ broad and established customer base in North America and Europe,” said Don Southard, president and CEO of Infraredx. “This resale agreement advances our global commercialization strategy by increasing our product’s penetration in the cardiac imaging market.”

Infraredx and Philips previously launched a software solution in March 2013 to enable the integration of the TVC imaging system with Philips’ Allura Xper and AlluraClarity interventional X-ray systems. The software enables an easy and quick setup of the TVC imaging system in conjunction with Philips’ Allura systems, and it allows clinicians tableside control of the TVC imaging system using the Allura system controls.

Clinicians can view a TVC composite image, which shows both the near-infrared spectroscopy image and the IVUS image, alongside the coronary angiogram on the Philips Allura monitors. The TVC composite image allows for better visualization of LCPs, which are known to cause complications in percutaneous coronary intervention (PCI) procedures and suspected of being the principal cause of most heart attacks. 

For more information: www.healthcare.philips.com, www.infraredx.com

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init